Company Filing History:
Years Active: 2008
Title: Inger Nordén: Innovator in Pharmaceutical Formulations
Introduction
Inger Nordén is a notable inventor based in Höör, Sweden. He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on extended release technologies. His innovative work has the potential to enhance drug delivery systems, improving patient outcomes.
Latest Patents
Inger Nordén holds a patent for a pharmaceutical formulation that features an extended release mechanism. This invention concerns a formulation with an accelerating erosion and/or dissolution rate of the surface. The formulation comprises a drug with low solubility in water, which is either dispersed or dissolved in at least one erasable hydrophilic polymeric matrix. This advancement is crucial for developing more effective medications.
Career Highlights
Inger Nordén is associated with Watson Pharmaceuticals, Inc., where he applies his expertise in pharmaceutical sciences. His work at the company has allowed him to collaborate with other professionals in the field, contributing to the advancement of drug formulation technologies.
Collaborations
Inger has worked alongside talented colleagues, including Catarina Carling and Peter Fyhr. Their combined efforts in research and development have fostered innovation in pharmaceutical formulations.
Conclusion
Inger Nordén's contributions to pharmaceutical formulations exemplify the importance of innovation in healthcare. His patent and collaborative efforts highlight the ongoing advancements in drug delivery systems.